Angiogenesis Inhibitors

Authored by: Shaker A. Mousa , Ahmed S. Mousa

Encyclopedia of Biomaterials and Biomedical Engineering, Second Edition

Print publication date:  May  2008
Online publication date:  May  2008

Print ISBN: 9781420078022
eBook ISBN: 9781498761437
Adobe ISBN:

10.1081/E-EBBE2-120013898

 Download Chapter

 

Abstract

The field of angiogenesis modulation is at a major crossroads. A tremendous advancement in basic science in this field is providing excellent support, though there is a lack of strong clinical support at this point with the exception of the recent data on anti-vascular endothelial growth factor (VEGF) as an adjunct to chemotherapy in solid tumor. Clinical outcome should include benefit/risk ratio, cost effectiveness, and hard end points including mortality, quality of life as opposed to tumor size reduction or decrease, and microvascular density with anti-angiogenesis agents.

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.